Evidence map›Paper›PMID 28427147›Full record

ArticleOncotarget2017

BRCA1 controls the cell division axis and governs ploidy and phenotype in human mammary cells.

Zhengcheng He, Nagarajan Kannan, Oksana Nemirovsky, Helen Chen, Marisa Connell, Brian Taylor, Jihong Jiang, Linda M Pilarski, Markus C Fleisch, Dieter Niederacher and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Progesterone and Breast Cancer.Endocrine reviews · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. eLife · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Zhengcheng HeDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Nagarajan KannanTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Oksana NemirovskyDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Helen ChenDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Marisa ConnellDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Brian TaylorDepartment of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
Jihong JiangDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
Linda M PilarskiDepartment of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada.
Markus C FleischDepartment of Obstetrics and Gynaecology, Landesfrauenklinik, HELIOS University Medical Center, Wuppertal, Germany.
Dieter NiederacherDepartment of Gynaecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Germany.
Miguel Angel PujanaBreast Cancer and Systems Biology Unit, Program Against Cancer Therapeutic Resistance (ProCure), Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
Connie J EavesTerry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Christopher A MaxwellDepartment of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
University of British Columbia · CABC Cancer Agency · CAUniversity of Alberta · CABC Children's Hospital · CADüsseldorf University Hospital · DEHelios Universitätsklinikum Wuppertal · DEInstitut Català d'Oncologia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BRCA1 deficiency may perturb the differentiation hierarchy present in the normal mammary gland and is associated with the genesis of breast cancers that are genomically unstable and typically display a basal-like transcriptome. Oriented cell division is a mechanism known to regulate cell fates and to restrict tumor formation. We now show that the cell division axis is altered following shRNA-mediated BRCA1 depletion in immortalized but non-tumorigenic, or freshly isolated normal human mammary cells with graded consequences in progeny cells that include aneuploidy, perturbation of cell polarity in spheroid cultures, and a selective loss of cells with luminal features. BRCA1 depletion stabilizes HMMR abundance and disrupts cortical asymmetry of NUMA-dynein complexes in dividing cells such that polarity cues provided by cell-matrix adhesions were not able to orient division. We also show that immortalized mammary cells carrying a mutant BRCA1 allele (BRCA1 185delAG/+) reproduce many of these effects but in this model, oriented divisions were maintained through cues provided by CDH1+ cell-cell junctions. These findings reveal a previously unknown effect of BRCA1 suppression on mechanisms that regulate the cell division axis in proliferating, non-transformed human mammary epithelial cells and consequent downstream effects on the mitotic integrity and phenotype control of their progeny.

Indexed as

BRCA1 ProteinBreast NeoplasmsCell DifferentiationCell DivisionEpithelial CellsFemaleHeLa CellsHumansPhenotypePloidiesBRCA1 ProteinBRCA1 protein, humanBRCA1human mammary epithelial cellsmitotic instabilityspindle orientation

Identifiers

PMID28427147
PMCPMC5464802
OpenAlexW2590310581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.